发明申请
US20120149706A1 INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
审中-公开
使用取代的杂环类抗生素抑制P38激酶活性
- 专利标题： INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
- 专利标题（中）： 使用取代的杂环类抗生素抑制P38激酶活性
-
申请号： US13401272申请日： 2012-02-21
-
公开(公告)号： US20120149706A1公开(公告)日： 2012-06-14
- 发明人: Jacques DUMAS , Uday KHIRE , Timothy B. Lowinger , Holger PAULSEN , Bernd RIEDL , Willian J. SCOTT , Roger A. SMITH , Jill WOOD , Holia HATOUM-MOKDAD , Wendy LEE , Aniko REDMAN , Jeffrey JOHNSON , Robert SIBLEY
- 申请人： Jacques DUMAS , Uday KHIRE , Timothy B. Lowinger , Holger PAULSEN , Bernd RIEDL , Willian J. SCOTT , Roger A. SMITH , Jill WOOD , Holia HATOUM-MOKDAD , Wendy LEE , Aniko REDMAN , Jeffrey JOHNSON , Robert SIBLEY
- 主分类号： A61K31/42
- IPC分类号： A61K31/42 ; C07D413/12 ; A61K31/4439 ; A61K31/497 ; A61K31/506 ; A61P37/06 ; A61P29/00 ; A61P37/02 ; A61P19/10 ; A61P19/02 ; A61P11/06 ; A61P1/00 ; C07D261/14 ; A61K31/5377
摘要：
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.